- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
An appeals court in Indiana upheld Eli Lilly's patent regarding Alimta, a major cancer drug for Lilly, keeping Teva and other generic drug specialists at bay.
The small business survey signals more building, more hiring, and more buying, Jim Cramer says.
Jim Cramer's bullish on SLB, AVGO, NUE and FRT. He's bearish on ESV, TEVA.